Review Article

Current Status of Sodium Bicarbonate in Coronary Angiography: An Updated Comprehensive Meta-Analysis and Systematic Review

Table 2

Clinical outcomes of included studies.
(a)

AuthorCINHemodialysis Changes of serum levels of creatinine Changes of serum levels of sodium bicarbonate
SBSCSBSCSBSCSBSC

Sodium bicarbonate versus saline
Boucek et al. [13]750014 ± 319 ± 26N.DN.D
Brar et al. [14]26301211 ± 30.69.3 ± 26.9N.DN.D
Alessandri et al. [19]1015N.DN.DN.DN.DN.DN.D
REINFORCE trial [15]32321.7 ± 12.62.3 ± 11.8N.DN.D
Yang et al. [20]85N.DN.DN.DN.DN.DN.D
Vasheghani-Farahani et al. [21]12N.DN.DN.DN.DN.DN.D
Vasheghani-Farahani et al. [16]44N.DN.D−3.35 ± 21−0.3 ± 18N.DN.D
CINSTEMI trial [22]334300N.DN.DN.DN.D
Ueda et al. [23]2800N.DN.DN.DN.D
Tamura et al. [24]9101N.DN.DN.DN.D
Shavit et al. [25]5300N.DN.DN.DN.D
RENO trial [26]11213N.DN.DN.DN.D
Ratcliffe et al. [17]21N.DN.D14.14 ± 12.3810.6 ± 29.1N.DN.D
Pakfetrat et al. [27]41200N.DN.DN.DN.D
Ozcan et al. [28]41211N.DN.DN.DN.D
Motohiro et al. [29]21000N.DN.D1.87 ± 1.430.12 ± 1.24
Merten et al. [30]1800N.DN.D2.1 ± 2.6−0.7 ± 2.8
Masuda et al. [31]21013N.DN.D3.2 ± 3.30.5 ± 3.1
Maioli et al. [32]252911N.DN.DN.DN.D
PREVENT trial [33]101741N.DN.D−0.49 ± 4.62−2.58 ± 8.75
Koc et al. [34]177N.DN.DN.DN.DN.DN.D
Klima et al. [35]15220N.DN.D2.2 ± 2.7−1.6 ± 2.3
Heguilén et al. [36]36N.DN.DN.DN.DN.DN.D
Hafiz et al. [37]1419N.DN.DN.DN.DN.DN.D
Gomes et al. [38]9900N.DN.DN.DN.D
Castini et al. [39]131100N.DN.DN.DN.D
Briguori et al. [40]21111N.DN.DN.DN.D
Mahmoodi et al. [18]1234N.DN.D−0.17 ± 0.020.08 ± 0.02N.DN.D

Author CIN Hemodialysis Changes of serum levels of creatinine Changes of serum levels of sodium bicarbonate
SBSB + NACSBSB + NACSBSB + NACSBSB + NAC

Sodium bicarbonate versus sodium bicarbonate plus N-acetyl cysteine
Thayssen et al. (CINSTEMI trial) [22]333300
Yang et al. [20]88N.DN.D
Ratcliffe et al. [17]21N.DN.D
Heguilén et al. [36]153N.DN.D
Heng et al. [41]32N.DN.D

(b)

Author Changes of serum levels of potassiumLength of hospital stayMortalityMACEJadad
SBSCSBSCSBSCSBSC

Sodium bicarbonate versus saline
Boucek et al. [13]N.DN.D8.4 ± 12.98 ± 1000334
Brar et al. [14]N.DN.DN.DN.D33484
Alessandri et al. [19]N.DN.DN.DN.DN.DN.DN.DN.D3
REINFORCE trial [15]N.DN.DN.DN.DN.DN.DN.DN.D5
Yang et al. [20]N.DN.DN.DN.DN.DN.DN.DN.D3
Vasheghani-Farahani et al. [21]N.DN.D1.5 ± 54.5 ± 3N.DN.DN.DN.D5
Vasheghani-Farahani et al. [16]N.DN.D1 ± 31 ± 6N.DN.DN.DN.D5
CINSTEMI trial [22]N.DN.DN.DN.DN.DN.DN.DN.D3
Ueda et al. [23]N.DN.D22.8 ± 17.921.4 ± 19.6289104
Tamura et al. [24]N.DN.DN.DN.D00003
Shavit et al. [25]N.DN.DN.DN.DN.DN.DN.DN.D2
RENO trial [26]N.DN.DN.DN.D14N.DN.D2
Ratcliffe et al. [17]N.DN.DN.DN.DN.DN.D003
Pakfetrat et al. [27]N.DN.DN.DN.D00N.DN.D5
Ozcan et al. [28]N.DN.DN.DN.DN.DN.D002
Motohiro et al. [29]−0.46 ± 0.61−0.32 ± 0.38N.DN.D00003
Merten et al. [30]−0.26 ± 0.48−0.17 ± 0.59N.DN.DN.DN.DN.DN.D3
Masuda et al. [31]N.DN.DN.DN.D02N.DN.D3
Maioli et al. [32]N.DN.DN.DN.D43N.DN.D5
PREVENT trial [33]−0.3 ± 0.58−0.23 ± 0.52N.DN.D011035
Koc et al. [34]N.DN.DN.DN.DN.DN.DN.DN.D2
Klima et al. [35]N.DN.DN.DN.D54N.DN.D4
Heguilén et al. [36]N.DN.DN.DN.DN.DN.DN.DN.D3
Hafiz et al. [37]N.DN.DN.DN.D00003
Gomes et al. [38]N.DN.D7.5 ± 108.6 ± 9.775N.DN.D2
Castini et al. [39]N.DN.DN.DN.DN.DN.DN.DN.D2
Briguori et al. [40]N.DN.DN.DN.DN.DN.DN.DN.D3
Mahmoodi et al. [18]N.DN.DN.DN.D00N.DN.D2

Author changes of serum levels of potassium Length of hospital stay Mortality MACEJadad
SBSB + NACSBSB + NACSBSB + NACSBSB + NAC

Sodium bicarbonate versus sodium bicarbonate plus N-acetyl cysteine
Thayssen et al. (CINSTEMI trial) [22]633
Yang et al. [20]N.DN.D3
Ratcliffe et al. [17]003
Heguilén et al. [36]N.DN.D3
Heng et al. [41]N.DN.D3